CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 236 enrolled
Drug / intervention
Medial-Olivocochlear Reflex (MOCR) Strength Measurementother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04749524
NCT04749524N/ACompleted

Otoacoustic Emission Suppression in Clinical Populations

Intelligent Hearing Systems·observational·Posted Feb 11, 2021·Updated Aug 16, 2024

In Brief

An observational study evaluating Medial-Olivocochlear Reflex (MOCR) Strength Measurement for Neonatal Hearing Loss. Completed, enrolled 236 participants across 1 site.

Detailed Summary

The focus of this project is on a physiologic auditory response called the Medial Olivocochlear Reflex (MOCR) that assesses peripheral neural function. While neural hearing loss is a significant auditory disorder in patients of all ages, more than 50% of newborn infants are screened with a technology that is not sensitive to abnormalities in neural function. The development of a time-efficient and sensitive test system to assess the MOCR will provide significant benefit to infants and patients of all ages with neural deficits who would otherwise go undetected.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 11, 2021
Enrollment StartApr 1, 2020
Primary CompletionJun 23, 2023
Study CompletionJul 12, 2023
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 5.4 years ago

Interventions

Medial-Olivocochlear Reflex (MOCR) Strength Measurementother

Otoacoustic emissions (OAE) will be recorded using an ear probe with and without an efferent Medial-Olivocochlear Reflex (MOCR) elicitor.